New Products of the Month

October 30, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every...
Read More

Meet with Us @ CVG 2019 Seminar

October 15, 2019
If you are interested in preparation and characterization of pharmaceutical reference standards, join us at CVG* 2019 Evening Seminar hosted by Covar Pharmaceuticals Inc. on Oct. 17. John Tobin, Director...
Read More

Recently Added Compounds (Ecopipam Certified Reference Standards)

June 12, 2019
Below are the highlights of products added in May 2019. All products are fully certified with detailed certificates of analysis. Ecopipam-13C6 (racemic) as HCl; Catalogue No. E-90426-01 Ecopipam Desmethyl 13C6 (racemic)...
Read More

New Products

March 21, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every...
Read More

New Clindamycin-Related Analytical Reference Standards

January 25, 2019
Acanthus Research Inc. now offers a large collection of clindamycin-related analytical reference standards. All standards are of high purity and are accompanied by Certificate of Analysis. Clindamycin (Cleocin HCl, Dalacin,...
Read More

New Calcipotriol EP Impurities A, C, D, F, and I

February 10, 2015
Acanthus Research Inc. has expanded its offering of Calcipotriol EP Impurities (A, C, D, F and I). Click here to view the structures. Each impurity standard is accompanied with a Certificate of...
Read More

Clindamycin-Related Analytical Reference Standards

February 2, 2015
Acanthus Research Inc. now offers a large collection of clindamycin-related analytical reference standards. All standards are of high purity and are accompanied by Certificate of Analysis. To request the CofA...
Read More

Nilotinib Potentially Genotoxic Impurities

February 2, 2015
Analytical reference standards of three potentially genotoxic impurities of nilotinib (Tasigna) are now available from Acanthus Research: Nilotinib Genotoxic Impurity 1 (CAS No. 641571-11-1), Nilotinib Genotoxic Impurity 2 (CAS No.1157857-29-8), and...
Read More

Lapatinib Potentially Genotoxic Impurities

February 1, 2015
Analytical reference standards of two potentially genotoxic impurities of lapatinib (Tykerb, Tyverb) are now available from Acanthus Research Inc.: Lapatinib Genotoxic Impurity 1 (CAS No. 202197-26-0) and Lapatinib Genotoxic Impurity 2 (CAS...
Read More

Control of Potentially Genotoxic Impurities in Drug Products

January 1, 2015
Genotoxin is a substance capable of damaging DNA causing mutations (mutagen), cancer (carcinogen), or birth defect (teratogen). The European and North American regulatory agencies recognized in mid 2000’s the importance...
Read More